# Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

Study · id `cardio:ct-nct07613840` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07613840](<https://clinicaltrials.gov/study/NCT07613840>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07613840

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 484 participants.

## Technical summary

Registry record NCT07613840. Randomized; no masking; primary purpose treatment. Start 2025-04-29 (actual); primary completion 2027-04-29 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 484 participants (planned count; ClinicalTrials.gov record NCT07613840, source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)
- Started: 2025-04-29 (actual) (ClinicalTrials.gov record NCT07613840, source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)
- Primary completion: 2027-04-29 (anticipated) (ClinicalTrials.gov record NCT07613840, source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07613840, source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07613840, source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07613840-2026-09-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
- Condition: Peripheral Arterial Disease (PAD)
- Condition: Amputation
- Condition: Thrombosis
- Condition: Thrombosis (Stent Thrombosis)
- Condition: Platelet Aggregation Inhibitors
- Condition: Thromboelastography (TEG)
- Condition: PRU(Platelet Reactivity Unit)
- Intervention (Drug): Aspirin
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Rivaroxaban
- Intervention (Device): Thromboelastography with Platelet Mapping
- Lead sponsor: Massachusetts General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry lists this organization as the lead sponsor: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 657031e2419a2fdbaa568f17d5add04748187ee74350b0d905222f9c4ae2de4c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
